サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1624349

細胞治療市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2034年

Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 161 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
細胞治療市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2034年
出版日: 2024年11月28日
発行: Transparency Market Research
ページ情報: 英文 161 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞治療市場 - 調査範囲

世界の細胞治療市場に関するTMRの調査レポートは、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の細胞治療市場の収益と予測を提供しています。また、2024年から2034年までの世界の細胞治療市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、細胞治療市場を推察しました。

市場スナップショット
2023年の市場金額 48億米ドル
2034年の市場金額 446億米ドル
CAGR 20.8%

当レポートでは、世界の細胞治療市場の競合情勢について調査しています。世界の細胞治療市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の細胞治療市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020年～2034年

第5章 主要洞察

  • ポーターのファイブフォース分析
  • PEST分析
  • 主要な業界イベント - 製品承認
  • 主要な業界イベント - パートナーシップ・コラボレーション

第6章 世界の市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主要な調査結果 / 発展
  • 市場金額予測：タイプ別、2020年～2034年
    • T細胞療法
      • キメラ抗原受容体（CAR）T細胞
      • T細胞受容体
      • 腫瘍浸潤リンパ球
    • 幹細胞療法
    • ナチュラルキラー細胞
    • 樹状細胞
    • その他の細胞療法
  • 市場の魅力：タイプ別

第7章 世界の市場分析と予測：起源別

  • イントロダクションと定義
  • 主要な調査結果 / 発展
  • 市場金額予測：起源別、2020年～2034年
    • 自家療法
    • 同種療法
  • 市場の魅力：起源別

第8章 世界の市場分析と予測：治療領域別

  • イントロダクションと定義
  • 主要な調査結果 / 発展
  • 市場金額予測：治療領域別、2020年～2034年
    • 腫瘍性疾患
    • 自己免疫疾患
    • 神経疾患
    • その他
  • 市場の魅力：治療領域別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域

第12章 アジア太平洋の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリア・ニュージーランド
  • その他アジア太平洋

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業 - 競合マトリックス（企業階層と規模別）
  • 市場シェア分析企業別（2023年）
  • 企業プロファイル
    • Novartis AG
    • Bristol-Myers Squibb Company
    • IOVANCE Biotherapeutics, Inc.
    • Janssen Biotech, Inc.
    • CellTrans, Inc.
    • Gamida Cell Inc.
    • Dendreon Pharmaceuticals LLC
    • Kite Pharma, Inc.
    • Adaptimmune
    • Takeda Pharmaceutical Company Limited
図表

List of Tables

  • Table 01: Global Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 03: Global Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 04: Global Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 05: Global Cell Therapy Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 08: North America Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 09: North America Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 10: North America Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 11: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 13: Europe Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 14: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 15: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 16: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 18: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 19: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 20: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 21: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 23: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 24: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 25: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 26: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 28: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 29: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 30: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034

List of Figures

  • Figure 01: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 02: Global Cell Therapy Market Share Analysis, by Type, 2023
  • Figure 03: Global Cell Therapy Market Share Analysis, by Type, 2034
  • Figure 04: Global Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 05: Global Cell Therapy Market Value (US$ Mn), by T-cell Therapy, 2020-2034
  • Figure 06: Global Cell Therapy Market Value Share Analysis, by T-cell Therapy, 2024 and 2034
  • Figure 07: Global Cell Therapy Market Value (US$ Mn), by Stem Cell Therapy, 2020-2034
  • Figure 08: Global Cell Therapy Market Value Share Analysis, by Stem Cell Therapy, 2024 and 2034
  • Figure 09: Global Cell Therapy Market Value (US$ Mn), by Natural Killer Cells, 2020-2034
  • Figure 10: Global Cell Therapy Market Value Share Analysis, by Natural Killer Cells, 2024 and 2034
  • Figure 11: Global Cell Therapy Market Value (US$ Mn), by Dendritic Cells, 2020-2034
  • Figure 12: Global Cell Therapy Market Value Share Analysis, by Dendritic Cells, 2024 and 2034
  • Figure 13: Global Cell Therapy Market Value (US$ Mn), by Other Cell Therapies, 2020-2034
  • Figure 14: Global Cell Therapy Market Value Share Analysis, by Other Cell Therapies, 2024 and 2034
  • Figure 15: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 16: Global Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 17: Global Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 18: Global Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 19: Global Cell Therapy Market Value (US$ Mn), by Autologous Therapies, 2020-2034
  • Figure 20: Global Cell Therapy Market Value Share Analysis, by Autologous Therapies, 2024 and 2034
  • Figure 21: Global Cell Therapy Market Value (US$ Mn), by Allogenic Therapies, 2020-2034
  • Figure 22: Global Cell Therapy Market Value Share Analysis, by Allogenic Therapies, 2024 and 2034
  • Figure 23: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 24: Global Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 25: Global Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 26: Global Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 27: Global Cell Therapy Market Value (US$ Mn), by Oncological Disorders, 2020-2034
  • Figure 28: Global Cell Therapy Market Value Share Analysis, by Oncological Disorders, 2024 and 2034
  • Figure 29: Global Cell Therapy Market Value (US$ Mn), by Autoimmune Disorders, 2020-2034
  • Figure 30: Global Cell Therapy Market Value Share Analysis, by Autoimmune Disorders, 2024 and 2034
  • Figure 31: Global Cell Therapy Market Value (US$ Mn), by Neurological Disorders, 2020-2034
  • Figure 32: Global Cell Therapy Market Value Share Analysis, by Neurological Disorders, 2024 and 2034
  • Figure 33: Global Cell Therapy Market Value (US$ Mn), by Others, 2020-2034
  • Figure 34: Global Cell Therapy Market Value Share Analysis, by Others, 2024 and 2034
  • Figure 35: Global Cell Therapy Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 36: Global Cell Therapy Market Share Analysis, by Region, 2023
  • Figure 37: Global Cell Therapy Market Share Analysis, by Region, 2034
  • Figure 38: Global Cell Therapy Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 39: North America Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 40: North America Cell Therapy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 41: North America Cell Therapy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 42: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 43: North America Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 44: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 45: North America Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 46: North America Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 47: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 48: North America Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 49: North America Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 50: Europe Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 51: Europe Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 52: Europe Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 53: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 54: Europe Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 55: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 56: Europe Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 57: Europe Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 58: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 59: Europe Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 60: Europe Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 61: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 62: Asia Pacific Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 63: Asia Pacific Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 64: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 65: Asia Pacific Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 66: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 67: Asia Pacific Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 68: North America Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 69: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 70: Asia Pacific Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 71: Asia Pacific Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 72: Latin America Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 73: Latin America Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 74: Latin America Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 75: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 76: Latin America Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 77: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 78: Latin America Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 79: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 80: Latin America Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 81: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 82: Middle East & Africa Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 83: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 84: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 85: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 86: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 87: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 88: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 89: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
目次
Product Code: TMRGL63273

Cell Therapy Market - Scope of Report

TMR's report on the global cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global cell therapy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell therapy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cell therapy market.

Market Snapshot
Market Value in 2023US$ 4.8 Bn
Market Value in 2034US$ 44.6 Bn
CAGR20.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell therapy market.

The report delves into the competitive landscape of the global cell therapy market. Key players operating in the global cell therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell therapy market profiled in this report.

Key Questions Answered in Global cell therapy Market Report:

  • What is the sales/revenue generated by cell therapy across all regions during the forecast period?
  • What are the opportunities in the global cell therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cell Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global cell therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cell therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell therapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cell Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cell Therapy Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Key Industry Events - Product Approvals
  • 5.4. Key Industry Events - Partnerships and Collaborations

6. Global Cell Therapy Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2034
    • 6.3.1. T-cell Therapy
      • 6.3.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 6.3.1.2. T-cell Receptors
      • 6.3.1.3. Tumor-Infiltrating Lymphocytes
    • 6.3.2. Stem Cell Therapy
    • 6.3.3. Natural Killer Cells
    • 6.3.4. Dendritic Cells
    • 6.3.5. Other Cell Therapies
  • 6.4. Market Attractiveness By Type

7. Global Cell Therapy Market Analysis and Forecasts, By Origin

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Origin, 2020-2034
    • 7.3.1. Autologous Therapies
    • 7.3.2. Allogenic Therapies
  • 7.4. Market Attractiveness By Origin

8. Global Cell Therapy Market Analysis and Forecasts, By Therapeutic Area

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Therapeutic Area, 2020-2034
    • 8.3.1. Oncological Disorders
    • 8.3.2. Autoimmune Disorders
    • 8.3.3. Neurological Disorders
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Therapeutic Area

9. Global Cell Therapy Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Cell Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type, 2020-2034
    • 10.2.1. T-cell Therapy
      • 10.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 10.2.1.2. T-cell Receptors
      • 10.2.1.3. Tumor-Infiltrating Lymphocytes
    • 10.2.2. Stem Cell Therapy
    • 10.2.3. Natural Killer Cells
    • 10.2.4. Dendritic Cells
    • 10.2.5. Other Cell Therapies
  • 10.3. Market Value Forecast By Origin, 2020-2034
    • 10.3.1. Autologous Therapies
    • 10.3.2. Allogenic Therapies
  • 10.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 10.4.1. Oncological Disorders
    • 10.4.2. Autoimmune Disorders
    • 10.4.3. Neurological Disorders
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Origin
    • 10.6.3. By Therapeutic Area
    • 10.6.4. By Country

11. Europe Cell Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2034
    • 11.2.1. T-cell Therapy
      • 11.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 11.2.1.2. T-cell Receptors
      • 11.2.1.3. Tumor-Infiltrating Lymphocytes
    • 11.2.2. Stem Cell Therapy
    • 11.2.3. Natural Killer Cells
    • 11.2.4. Dendritic Cells
    • 11.2.5. Other Cell Therapies
  • 11.3. Market Value Forecast By Origin, 2020-2034
    • 11.3.1. Autologous Therapies
    • 11.3.2. Allogenic Therapies
  • 11.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 11.4.1. Oncological Disorders
    • 11.4.2. Autoimmune Disorders
    • 11.4.3. Neurological Disorders
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Origin
    • 11.6.3. By Therapeutic Area
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Cell Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2034
    • 12.2.1. T-cell Therapy
      • 12.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 12.2.1.2. T-cell Receptors
      • 12.2.1.3. Tumor-Infiltrating Lymphocytes
    • 12.2.2. Stem Cell Therapy
    • 12.2.3. Natural Killer Cells
    • 12.2.4. Dendritic Cells
    • 12.2.5. Other Cell Therapies
  • 12.3. Market Value Forecast By Origin, 2020-2034
    • 12.3.1. Autologous Therapies
    • 12.3.2. Allogenic Therapies
  • 12.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 12.4.1. Oncological Disorders
    • 12.4.2. Autoimmune Disorders
    • 12.4.3. Neurological Disorders
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Origin
    • 12.6.3. By Therapeutic Area
    • 12.6.4. By Country/Sub-region

13. Latin America Cell Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2034
    • 13.2.1. T-cell Therapy
      • 13.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 13.2.1.2. T-cell Receptors
      • 13.2.1.3. Tumor-Infiltrating Lymphocytes
    • 13.2.2. Stem Cell Therapy
    • 13.2.3. Natural Killer Cells
    • 13.2.4. Dendritic Cells
    • 13.2.5. Other Cell Therapies
  • 13.3. Market Value Forecast By Origin, 2020-2034
    • 13.3.1. Autologous Therapies
    • 13.3.2. Allogenic Therapies
  • 13.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 13.4.1. Oncological Disorders
    • 13.4.2. Autoimmune Disorders
    • 13.4.3. Neurological Disorders
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Origin
    • 13.6.3. By Therapeutic Area
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Cell Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2034
    • 14.2.1. T-cell Therapy
      • 14.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 14.2.1.2. T-cell Receptors
      • 14.2.1.3. Tumor-Infiltrating Lymphocytes
    • 14.2.2. Stem Cell Therapy
    • 14.2.3. Natural Killer Cells
    • 14.2.4. Dendritic Cells
    • 14.2.5. Other Cell Therapies
  • 14.3. Market Value Forecast By Origin, 2020-2034
    • 14.3.1. Autologous Therapies
    • 14.3.2. Allogenic Therapies
  • 14.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 14.4.1. Oncological Disorders
    • 14.4.2. Autoimmune Disorders
    • 14.4.3. Neurological Disorders
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.5.1. GCC
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Origin
    • 14.6.3. By Therapeutic Area
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Novartis AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Bristol-Myers Squibb Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. IOVANCE Biotherapeutics, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Janssen Biotech, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. CellTrans, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Gamida Cell Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Dendreon Pharmaceuticals LLC
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Kite Pharma, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Adaptimmune
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Takeda Pharmaceutical Company Limited
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments